These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry. Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864 [TBL] [Abstract][Full Text] [Related]
8. Caffeine consumption and methotrexate dosing requirement in psoriasis and psoriatic arthritis. Swanson DL; Barnes SA; Mengden Koon SJ; el-Azhary RA Int J Dermatol; 2007 Feb; 46(2):157-9. PubMed ID: 17269967 [TBL] [Abstract][Full Text] [Related]
9. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368 [TBL] [Abstract][Full Text] [Related]
10. [The treatment of psoriasis-arthritis with cyclosporin A, a new immunosuppressive agent]. Müller W; Graf U Schweiz Med Wochenschr; 1981 Mar; 111(12):408-13. PubMed ID: 7221517 [TBL] [Abstract][Full Text] [Related]
11. Short-term cyclosporin monotherapy for chronic severe plaque-type psoriasis. Jan V; Vaillant L; Bressieux JM; Barthélemy H; Legoux A; Steiner HG; Reigneau O Eur J Dermatol; 1999 Dec; 9(8):615-7. PubMed ID: 10586127 [TBL] [Abstract][Full Text] [Related]
12. Leflunomide in psoriasis and psoriatic arthritis: a preliminary study. Thami GP; Garg G Arch Dermatol; 2004 Oct; 140(10):1288-9. PubMed ID: 15492204 [No Abstract] [Full Text] [Related]
13. [Our experience with infliximab in reclacitrant cases of psoriasis]. Pereiro M; González-Vilas D; Sánchez-Aguilar D; Toribio J Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():43-7. PubMed ID: 19080991 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A and psoriasis: a thermographic study. Ippolito F; Di Carlo A; Carducci M; Leone G; Frascione P Acta Derm Venereol Suppl (Stockh); 1989; 146():155-8. PubMed ID: 2609858 [TBL] [Abstract][Full Text] [Related]
16. Rapid response of von Zumbusch psoriasis to cyclosporine. Fradin MS; Ellis CN; Voorhees JJ J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):925-6. PubMed ID: 2254478 [No Abstract] [Full Text] [Related]
17. The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety. Yamauchi PS; Gindi V; Lowe NJ Dermatol Clin; 2004 Oct; 22(4):449-59, ix. PubMed ID: 15450340 [TBL] [Abstract][Full Text] [Related]
18. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699 [TBL] [Abstract][Full Text] [Related]
19. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis. Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570 [TBL] [Abstract][Full Text] [Related]